Insight

Matt Katz, Nick Kramer Publish Article in Chain Drug Review: “Digital Transformation Opens Up New Opportunities”

< BACK TO INSIGHTS

Insight

Matt Katz, Nick Kramer Publish Article in Chain Drug Review: “Digital Transformation Opens Up New Opportunities”

Matt Katz, Managing Partner and Head of Retail & Consumer Packaged Goods, Nick Kramer, Vice President of Digital and Analytics, and Chris Ventry, Vice President of Retail & Consumer Packaged Goods, recently published an article in Chain Drug Review. The trio takes a look at the impact of the COVID-19 pandemic on chain drug stores and how digital transformation can reimagine business and operating models to preserve market share, seize opportunity, and control operating expense.

 

Chain Drug Review July 27 2020

Authors

Related Services

Recommended Insights

Insight

Wharton CIO Alternative Investments Summit

SSA & Company was proud to have participated in the CIO Alternative Investments Summit hosted by Wharton Private Equity & Venture Capital Alumni Association.  We were honored to partner with our colleagues across Council Advisors and The Miles Group to serve as a gold-level sponsor, supporting this forum where leaders from private equity, venture capital, hedge funds, family offices, and more shared insights on the evolving world of alternative investments.

Learn More

Insight

Despite Successive Interest Rate Cuts, the $2.7 Trillion Commercial Real Estate Problem Isn’t Going Away

Pierre Buhler and Andrew Jones discuss the future state of the commercial real estate market in this ABF Journal article.

Learn More

Insight

Growth Equity Today: Adapting Buyout Playbooks to Accelerate Performance

Growth equity firms today face extraordinary market characteristics. Hold periods have extended, many investments are ‘upside down,’ and fund IRRs, on average, have turned negative. Additionally, capital costs have increased, and raising capital has grown increasingly difficult.

Learn More

Stay up-to-date with our latest news

Name(Required)